This inventor holds 1 USPTO granted patent. Top assignee: Nanjing China-Australia Institute of Translational Medicine Co. Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Liping Lin in Cancer Treatment
Introduction
Liping Lin is a notable inventor based in Jiangsu, China, recognized for her contributions to the field of cancer treatment. She has made significant strides in developing innovative therapies aimed at combating non-small cell lung cancer.
Latest Patents
Liping Lin holds a patent for the use of AURKB small-molecule inhibitors for the treatment of non-small cell lung cancer. This patent discloses the use of a small-molecule AURKB inhibitor directed to a diindolylmethane compound, which can be utilized in various forms, including solvates, N-oxides, or pharmaceutically acceptable salts.
Career Highlights
Liping Lin is affiliated with the Nanjing China-Australia Institute of Translational Medicine Co. Ltd., where she continues to advance her research and development efforts in oncology. Her work is pivotal in the ongoing fight against cancer, particularly in enhancing treatment options for patients.
Collaborations
Liping Lin collaborates with esteemed colleagues such as Quan Zhao and Renxiang Tan, contributing to a dynamic research environment focused on innovative cancer therapies.
Conclusion
Liping Lin's innovative work in the field of cancer treatment exemplifies the impact of dedicated research and development in improving patient outcomes. Her contributions are vital in the ongoing battle against non-small cell lung cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile